bipolar%20disorder
BIPOLAR DISORDER
Bipolar I disorder is primarily defined by manic or mixed episodes that last for at least 7 days, or very severe manic symptoms needing immediate hospital care. The patient also has depressive episodes which may last for at least 2 weeks.
Bipolar II disorder is usually misdiagnosed. It is characterized by occurence of ≥1 major depressive episodes with at least 1 hypomanic episode.
Cyclothymic disorder or cyclothymia is a mild form of bipolar disorder. Patients have  episodes of hypomania alternating with mild depression that lasts for 2 years.
Rapid-cycling bipolar disorder patients have ≥4 episodes of major depression, mania, hypomania or mixed symptoms within a year.

Bipolar Disorder Drug Information

Drug Information

Indication: Maintenance treatment of schizophrenia in adult patients.

Indication: Schizophrenia. Mono- & adjunct therapy for acute treatment of manic or mixed episodes associated w/ bipola...

Indication: Patients w/ schizophrenia who are non-responsive to or intolerant of classic antipsychotics. Recurrent suicida...

Indication: Schizophrenia in adolescents ≥15 yr including acute treatment & recurrence prevention. Acute exacerbati...

Indication: Acute & maintenance treatment of schizophrenia in adults. Schizoaffective disorder in adults as monotherap...

Indication: Risperdal Schizophrenia including 1st episode psychoses, acute schizophrenic exacerbations, chronic schizophre...

Indication: Acute & maintenance treatment of schizoprenia. Acute manic episodes associated w/ bipolar I disorder.

Indication: Schizophrenia & acute manic episodes w/ bipolar I disorder.

Indication: Adjunctive or monotherapy in treatment of epilepsy for partial & generalized seizures, including tonic-clo...

Indication: Acute & maintenance treatment of schizophrenia & other psychoses where +ve &/or -ve symptoms are p...

1  /  4
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elvira Manzano, 2 days ago
Monthly injections of the PCSK9* monoclonal antibody evolocumab effectively reduced plasma LDL-cholesterol (LDL-C), often referred to as the bad cholesterol, in teenagers with heterozygous familial hypercholesterolaemia (HeFH) already taking statins, with or without ezetimibe, the HAUSER-RCT has shown.
Jairia Dela Cruz, 3 days ago
For individuals with type 2 diabetes, losing weight is everything when it comes to improving the metabolic function, and it matters little whether this is achieved by dieting or undergoing bariatric surgery, according to a small study.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
3 days ago
In patients with type 2 diabetes (T2D), postprandial hyperglycaemia and hypertriglyceridemia worsens survival outlook, finds a new study.